相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
Jonathan Corren et al.
JOURNAL OF ASTHMA AND ALLERGY (2021)
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
Jonathan Corren et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation
Audrey Le Floc'h et al.
ALLERGY (2020)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis
William W. Busse et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data
Pavel Kovalenko et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2020)
Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
Harsha H. Kariyawasam et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Claus Bachert et al.
LANCET (2019)
Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy
Mohamed H. Shamji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Mast cells and basophils in allergic inflammation
Masato Kubo
CURRENT OPINION IN IMMUNOLOGY (2018)
Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma
Steven F. Weinstein et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Commonality of the IL-4/IL-13 pathway in atopic diseases
Namita A. Gandhi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Exploratory Population PK Analysis of Dupilumab, a Fully Human Monoclonal Antibody Against IL-4R, in Atopic Dermatitis Patients and Normal Volunteers
P. Kovalenko et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study
M. Zidarn et al.
ALLERGY (2015)
Clinical Practice Guideline: Allergic Rhinitis
Michael D. Seidman et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2015)
Allergic Rhinitis: an Overview
Jitendra Varshney et al.
INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY (2015)
Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes
Lynn E. Macdonald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice
Andrew J. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies
Louisa K. James et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Triggers of IgE class switching and allergy development
Lars K. Poulsen et al.
ANNALS OF MEDICINE (2007)
Evaluation of near-fatal reactions to allergen immunotherapy injections
HS Amin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
The burden of allergic rhinitis: beyond dollars and cents
SM Fineman
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2002)
分享论文
